Literature DB >> 33401712

Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art.

Andrea Bassi1, Teresa Russo2, Giuseppe Argenziano2, Carlo Mazzatenta1, Elisabetta Venturini3, Iria Neri4, Vincenzo Piccolo2.   

Abstract

SARS-CoV-2 infection has spread all over the world in the last year, causing millions of COVID-19 cases among humans with a large variability of symptoms and signs, including those on the skin. Among these, a contemporary cluster of chilblain-like lesions with no certain relationship with the infection has been reported. The aim of this paper is to delineate a profile of chilblain-like lesions and to establish the state-of-the-art knowledge about this new phenomenon.

Entities:  

Keywords:  COVID-19; chilblain-like lesions; skin manifestation

Year:  2021        PMID： 33401712      PMCID： PMC7823415          DOI： 10.3390/life11010023

Source DB:  PubMed          Journal:  Life (Basel)        ISSN： 2075-1729


  23 in total

1.  Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.

Authors:  Anne Herman; Caroline Peeters; Alexia Verroken; Isabelle Tromme; Dominique Tennstedt; Liliane Marot; Claire Dachelet; Damien Gruson; Cedric Hermans; Marie Baeck
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

2.  Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.

Authors:  Pierre Sohier; Stéphanie Matar; Jean-François Meritet; Sara Laurent-Roussel; Nicolas Dupin; Selim Aractingi
Journal:  Arch Pathol Lab Med       Date:  2021-02-01       Impact factor: 5.534

3.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

4.  Silent COVID-19: what your skin can reveal.

Authors:  Claudio Guarneri; Emmanuele Venanzi Rullo; Piero Pavone; Massimiliano Berretta; Manuela Ceccarelli; Alfonso Natale; Giuseppe Nunnari
Journal:  Lancet Infect Dis       Date:  2020-05-18       Impact factor: 25.071

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Authors:  Takuya Sekine; André Perez-Potti; Olga Rivera-Ballesteros; Kristoffer Strålin; Jean-Baptiste Gorin; Annika Olsson; Sian Llewellyn-Lacey; Habiba Kamal; Gordana Bogdanovic; Sandra Muschiol; David J Wullimann; Tobias Kammann; Johanna Emgård; Tiphaine Parrot; Elin Folkesson; Olav Rooyackers; Lars I Eriksson; Jan-Inge Henter; Anders Sönnerborg; Tobias Allander; Jan Albert; Morten Nielsen; Jonas Klingström; Sara Gredmark-Russ; Niklas K Björkström; Johan K Sandberg; David A Price; Hans-Gustaf Ljunggren; Soo Aleman; Marcus Buggert
Journal:  Cell       Date:  2020-08-14       Impact factor: 41.582

7.  SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.

Authors:  I Colmenero; C Santonja; M Alonso-Riaño; L Noguera-Morel; A Hernández-Martín; D Andina; T Wiesner; J L Rodríguez-Peralto; L Requena; A Torrelo
Journal:  Br J Dermatol       Date:  2020-08-05       Impact factor: 11.113

8.  Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Authors:  V Piccolo; I Neri; C Filippeschi; T Oranges; G Argenziano; V C Battarra; S Berti; F Manunza; A B Fortina; V Di Lernia; V Boccaletti; G De Bernardis; B Brunetti; C Mazzatenta; A Bassi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

9.  A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?

Authors:  Dan Lipsker
Journal:  Med Hypotheses       Date:  2020-06-06       Impact factor: 1.538

10.  Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.

Authors:  Vincenzo Piccolo; Andrea Bassi; Giuseppe Argenziano; Carlo Mazzatenta; Alba Guglielmo; Annalisa Patrizi; Iria Neri
Journal:  J Am Acad Dermatol       Date:  2020-09-30       Impact factor: 11.527
View more
  7 in total

1.  BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.

Authors:  V Piccolo; A Bassi; G Argenziano; C Mazzatenta; M Cutrone; I Neri; R Grimalt; T Russo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-10       Impact factor: 9.228

2.  Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?

Authors:  S Signa; A R Sementa; M C Coccia; C Pastorino; G Viglizzo; S Viola; S Volpi; C Occella; D Bleidl; M Acquila; E Castagnola; A Ravelli; F Manunza
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-01       Impact factor: 9.228

3.  Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.

Authors:  V Piccolo; A Bassi; G Argenziano; C Mazzatenta; M Cutrone; I Neri; R Grimalt; T Russo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-07       Impact factor: 9.228

4.  Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees.

Authors:  A Bassi; C Mazzatenta; A Sechi; M Cutrone; V Piccolo
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-08       Impact factor: 9.228

Review 5.  [COVID-19 and skin manifestations: overview of current literature].

Authors:  Kristin Lange; Maja Matthies; Parnian Firouzi-Memarpuri; Bernhard Homey
Journal:  Hautarzt       Date:  2022-03-07       Impact factor: 0.751

6.  Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.

Authors:  Hélène Mascitti; Patrick Jourdain; Alexandre Bleibtreu; Luc Jaulmes; Agnès Dechartres; Xavier Lescure; Youri Yordanov; Aurélien Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-13       Impact factor: 3.267

7.  Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.

Authors:  Michela Starace; Matilde Iorizzo; Andrea Sechi; Aurora Maria Alessandrini; Miriam Carpanese; Francesca Bruni; Giulio Vara; Zoe Apalla; Daniel Asz-Sigall; Stefania Barruscotti; Francisco Camacho; Isabella Doche; Bruna Duque Estrada; Rachita Dhurat; Maria Fernanda Gavazzoni; Ramon Grimalt; Matthew Harries; Dimitrios Ioannidis; Amy McMichael; Daniel Fernandes Melo; Rui Oliveira; Yuliya Ovcharenko; Rodrigo Pirmez; Yuval Ramot; Lidia Rudnicka; Jerry Shapiro; Tatiana Silyuk; Rodney Sinclair; Antonella Tosti; Sergio Vano-Galvan; Bianca Maria Piraccini
Journal:  JAAD Int       Date:  2021-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.